NACDS continues to urge the vital need for reforms at the federal level that will prevent “pharmaceutical benefit manipulation” across all markets – Medicare, Medicaid and commercial.
Report: “The Committee’s findings indicate that the present role of PBMs in prescription drug markets is failing and requires change”
NACDS urges “tenacity” by House Oversight and Accountability Committee in its hearing and investigation.
A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S. House Committee on Oversight and Accountability hearing on PBM middlemen tactics.
HB 1993 includes important PBM reforms and protections for Pennsylvania families’ access to pharmacies for important services.
NACDS’ Nourish Ny Health initiative, a newly released Milken Institute Action Plan, and a Leavitt Partners report on pharmacy data interoperability are among the latest.
NACDS: “The Congress and states need no further validation for their bipartisan work to immediately confront pharmaceutical benefit manipulation that is devastating Americans, communities, and pharmacies of all sizes”
NACDS: “These harms are experienced brutally by pharmacies of diverse sizes and formats, including independents and chains, that do not receive preferential treatment from their vertically integrated plans and PBMs”
HB 579 will improve critical community access to care by enabling pharmacists to dispense HIV pre-exposure (PrEP) and post-exposure prophylaxis (PEP); becomes effective on August 1, 2024
Social campaign highlights member efforts to prioritize men’s health
Wyden letter urges Centers for Medicare & Medicaid Services to “conduct immediate oversight and rigorous regulatory enforcement of specific Medicare Part D program requirements for plan sponsors and their PBMs.”
NACDS also is urging Congress to enact in the 118th Congress PBM reforms in Medicare, Medicaid and the commercial markets: all levels and branches of government must do their jobs.
